nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimozide—DRD3—Gilles de la Tourette syndrome	0.388	0.449	CbGaD
Pimozide—DRD2—Gilles de la Tourette syndrome	0.268	0.311	CbGaD
Pimozide—HTR2A—Gilles de la Tourette syndrome	0.207	0.24	CbGaD
Pimozide—CALM1—autonomic nervous system—Gilles de la Tourette syndrome	0.00509	0.0999	CbGeAlD
Pimozide—HTR2A—autonomic nervous system—Gilles de la Tourette syndrome	0.0031	0.0608	CbGeAlD
Pimozide—CACNA1G—nervous system—Gilles de la Tourette syndrome	0.00197	0.0387	CbGeAlD
Pimozide—CACNA1G—central nervous system—Gilles de la Tourette syndrome	0.0019	0.0373	CbGeAlD
Pimozide—CACNA1G—brain—Gilles de la Tourette syndrome	0.00151	0.0296	CbGeAlD
Pimozide—DRD3—nervous system—Gilles de la Tourette syndrome	0.0014	0.0276	CbGeAlD
Pimozide—DRD3—central nervous system—Gilles de la Tourette syndrome	0.00135	0.0266	CbGeAlD
Pimozide—HTR6—nervous system—Gilles de la Tourette syndrome	0.00135	0.0265	CbGeAlD
Pimozide—HTR6—central nervous system—Gilles de la Tourette syndrome	0.0013	0.0256	CbGeAlD
Pimozide—OPRK1—nervous system—Gilles de la Tourette syndrome	0.00125	0.0246	CbGeAlD
Pimozide—Sertindole—DRD4—Gilles de la Tourette syndrome	0.00121	0.154	CrCbGaD
Pimozide—OPRK1—central nervous system—Gilles de la Tourette syndrome	0.00121	0.0237	CbGeAlD
Pimozide—Droperidol—DRD2—Gilles de la Tourette syndrome	0.00112	0.143	CrCbGaD
Pimozide—OPRM1—midbrain—Gilles de la Tourette syndrome	0.00108	0.0213	CbGeAlD
Pimozide—DRD3—brain—Gilles de la Tourette syndrome	0.00107	0.0211	CbGeAlD
Pimozide—Sertindole—DRD3—Gilles de la Tourette syndrome	0.00104	0.133	CrCbGaD
Pimozide—HTR6—brain—Gilles de la Tourette syndrome	0.00103	0.0203	CbGeAlD
Pimozide—CALM3—midbrain—Gilles de la Tourette syndrome	0.001	0.0197	CbGeAlD
Pimozide—OPRK1—brain—Gilles de la Tourette syndrome	0.000957	0.0188	CbGeAlD
Pimozide—OPRM1—nervous system—Gilles de la Tourette syndrome	0.000891	0.0175	CbGeAlD
Pimozide—Droperidol—HTR2A—Gilles de la Tourette syndrome	0.000866	0.11	CrCbGaD
Pimozide—OPRM1—central nervous system—Gilles de la Tourette syndrome	0.000857	0.0168	CbGeAlD
Pimozide—CHRM2—nervous system—Gilles de la Tourette syndrome	0.000811	0.0159	CbGeAlD
Pimozide—HTR1A—midbrain—Gilles de la Tourette syndrome	0.0008	0.0157	CbGeAlD
Pimozide—CALM2—midbrain—Gilles de la Tourette syndrome	0.000786	0.0154	CbGeAlD
Pimozide—CALM1—midbrain—Gilles de la Tourette syndrome	0.000783	0.0154	CbGeAlD
Pimozide—CHRM2—central nervous system—Gilles de la Tourette syndrome	0.00078	0.0153	CbGeAlD
Pimozide—Domperidone—DRD3—Gilles de la Tourette syndrome	0.000761	0.097	CrCbGaD
Pimozide—DRD2—midbrain—Gilles de la Tourette syndrome	0.000723	0.0142	CbGeAlD
Pimozide—Sertindole—DRD2—Gilles de la Tourette syndrome	0.000722	0.092	CrCbGaD
Pimozide—KCNH2—midbrain—Gilles de la Tourette syndrome	0.000712	0.014	CbGeAlD
Pimozide—OPRM1—brain—Gilles de la Tourette syndrome	0.000681	0.0134	CbGeAlD
Pimozide—HTR1A—nervous system—Gilles de la Tourette syndrome	0.000658	0.0129	CbGeAlD
Pimozide—CALM2—nervous system—Gilles de la Tourette syndrome	0.000646	0.0127	CbGeAlD
Pimozide—CALM1—nervous system—Gilles de la Tourette syndrome	0.000643	0.0126	CbGeAlD
Pimozide—HTR1A—central nervous system—Gilles de la Tourette syndrome	0.000633	0.0124	CbGeAlD
Pimozide—CALM3—brain—Gilles de la Tourette syndrome	0.000629	0.0124	CbGeAlD
Pimozide—CALM2—central nervous system—Gilles de la Tourette syndrome	0.000622	0.0122	CbGeAlD
Pimozide—CHRM2—brain—Gilles de la Tourette syndrome	0.00062	0.0122	CbGeAlD
Pimozide—CALM1—central nervous system—Gilles de la Tourette syndrome	0.000619	0.0122	CbGeAlD
Pimozide—DRD2—nervous system—Gilles de la Tourette syndrome	0.000594	0.0117	CbGeAlD
Pimozide—Fluspirilene—DRD2—Gilles de la Tourette syndrome	0.000589	0.075	CrCbGaD
Pimozide—KCNH2—nervous system—Gilles de la Tourette syndrome	0.000585	0.0115	CbGeAlD
Pimozide—DRD2—central nervous system—Gilles de la Tourette syndrome	0.000572	0.0112	CbGeAlD
Pimozide—KCNH2—central nervous system—Gilles de la Tourette syndrome	0.000564	0.0111	CbGeAlD
Pimozide—Sertindole—HTR2A—Gilles de la Tourette syndrome	0.000558	0.0711	CrCbGaD
Pimozide—Domperidone—DRD2—Gilles de la Tourette syndrome	0.000527	0.0671	CrCbGaD
Pimozide—HTR1A—brain—Gilles de la Tourette syndrome	0.000503	0.00987	CbGeAlD
Pimozide—CALM2—brain—Gilles de la Tourette syndrome	0.000494	0.0097	CbGeAlD
Pimozide—CALM1—brain—Gilles de la Tourette syndrome	0.000492	0.00966	CbGeAlD
Pimozide—HTR2A—midbrain—Gilles de la Tourette syndrome	0.000477	0.00936	CbGeAlD
Pimozide—HRH1—nervous system—Gilles de la Tourette syndrome	0.000469	0.00921	CbGeAlD
Pimozide—Fluspirilene—HTR2A—Gilles de la Tourette syndrome	0.000455	0.0579	CrCbGaD
Pimozide—DRD2—brain—Gilles de la Tourette syndrome	0.000454	0.00892	CbGeAlD
Pimozide—HRH1—central nervous system—Gilles de la Tourette syndrome	0.000452	0.00887	CbGeAlD
Pimozide—CYP2E1—nervous system—Gilles de la Tourette syndrome	0.000451	0.00885	CbGeAlD
Pimozide—KCNH2—brain—Gilles de la Tourette syndrome	0.000447	0.00879	CbGeAlD
Pimozide—CYP2E1—central nervous system—Gilles de la Tourette syndrome	0.000434	0.00852	CbGeAlD
Pimozide—HTR2A—nervous system—Gilles de la Tourette syndrome	0.000392	0.0077	CbGeAlD
Pimozide—HTR2A—central nervous system—Gilles de la Tourette syndrome	0.000377	0.00741	CbGeAlD
Pimozide—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.000363	0.00712	CbGeAlD
Pimozide—HRH1—brain—Gilles de la Tourette syndrome	0.000359	0.00704	CbGeAlD
Pimozide—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.000357	0.00701	CbGeAlD
Pimozide—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.000349	0.00686	CbGeAlD
Pimozide—CYP2E1—brain—Gilles de la Tourette syndrome	0.000345	0.00677	CbGeAlD
Pimozide—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.000344	0.00675	CbGeAlD
Pimozide—ABCB1—midbrain—Gilles de la Tourette syndrome	0.000312	0.00613	CbGeAlD
Pimozide—HTR2A—brain—Gilles de la Tourette syndrome	0.0003	0.00588	CbGeAlD
Pimozide—CYP2D6—brain—Gilles de la Tourette syndrome	0.000273	0.00536	CbGeAlD
Pimozide—ABCB1—nervous system—Gilles de la Tourette syndrome	0.000257	0.00504	CbGeAlD
Pimozide—ABCB1—central nervous system—Gilles de la Tourette syndrome	0.000247	0.00486	CbGeAlD
Pimozide—ABCB1—brain—Gilles de la Tourette syndrome	0.000196	0.00385	CbGeAlD
Pimozide—OPRM1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000158	0.00203	CbGpPWpGaD
Pimozide—HTR6—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000158	0.00203	CbGpPWpGaD
Pimozide—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000156	0.002	CbGpPWpGaD
Pimozide—OPRM1—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000154	0.00198	CbGpPWpGaD
Pimozide—OPRM1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000154	0.00197	CbGpPWpGaD
Pimozide—HTR6—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000154	0.00197	CbGpPWpGaD
Pimozide—DRD3—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000153	0.00196	CbGpPWpGaD
Pimozide—DRD3—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000152	0.00195	CbGpPWpGaD
Pimozide—HTR1A—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000147	0.00189	CbGpPWpGaD
Pimozide—DRD2—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.000147	0.00188	CbGpPWpGaD
Pimozide—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000145	0.00186	CbGpPWpGaD
Pimozide—OPRM1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000143	0.00184	CbGpPWpGaD
Pimozide—HTR6—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000143	0.00184	CbGpPWpGaD
Pimozide—HTR1A—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000143	0.00184	CbGpPWpGaD
Pimozide—DRD2—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.000142	0.00183	CbGpPWpGaD
Pimozide—DRD3—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000142	0.00182	CbGpPWpGaD
Pimozide—HTR1A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000137	0.00175	CbGpPWpGaD
Pimozide—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000136	0.00174	CbGpPWpGaD
Pimozide—HTR1A—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000133	0.00171	CbGpPWpGaD
Pimozide—HTR1A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000133	0.0017	CbGpPWpGaD
Pimozide—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000132	0.00169	CbGpPWpGaD
Pimozide—DRD3—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000131	0.00167	CbGpPWpGaD
Pimozide—HTR1A—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.00013	0.00166	CbGpPWpGaD
Pimozide—DRD2—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000129	0.00166	CbGpPWpGaD
Pimozide—CACNA1G—Developmental Biology—MET—Gilles de la Tourette syndrome	0.000127	0.00164	CbGpPWpGaD
Pimozide—DRD2—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000126	0.00161	CbGpPWpGaD
Pimozide—CHRM2—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000125	0.0016	CbGpPWpGaD
Pimozide—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000124	0.00159	CbGpPWpGaD
Pimozide—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000123	0.00158	CbGpPWpGaD
Pimozide—OPRK1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000122	0.00157	CbGpPWpGaD
Pimozide—DRD3—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000122	0.00156	CbGpPWpGaD
Pimozide—CHRM2—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000121	0.00156	CbGpPWpGaD
Pimozide—HTR6—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000121	0.00155	CbGpPWpGaD
Pimozide—DRD2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00012	0.00154	CbGpPWpGaD
Pimozide—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000119	0.00152	CbGpPWpGaD
Pimozide—OPRK1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000119	0.00152	CbGpPWpGaD
Pimozide—HTR2A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000118	0.00152	CbGpPWpGaD
Pimozide—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000118	0.00151	CbGpPWpGaD
Pimozide—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000117	0.0015	CbGpPWpGaD
Pimozide—HTR6—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000117	0.0015	CbGpPWpGaD
Pimozide—HTR6—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000117	0.0015	CbGpPWpGaD
Pimozide—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000117	0.0015	CbGpPWpGaD
Pimozide—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000116	0.00149	CbGpPWpGaD
Pimozide—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000115	0.00147	CbGpPWpGaD
Pimozide—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000114	0.00147	CbGpPWpGaD
Pimozide—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000114	0.00146	CbGpPWpGaD
Pimozide—CHRM2—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000113	0.00145	CbGpPWpGaD
Pimozide—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000113	0.00145	CbGpPWpGaD
Pimozide—CALM3—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.000111	0.00142	CbGpPWpGaD
Pimozide—OPRK1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000111	0.00142	CbGpPWpGaD
Pimozide—CHRM2—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.00011	0.00141	CbGpPWpGaD
Pimozide—HTR6—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000109	0.0014	CbGpPWpGaD
Pimozide—CALM2—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.000107	0.00137	CbGpPWpGaD
Pimozide—CALM1—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.000107	0.00137	CbGpPWpGaD
Pimozide—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000107	0.00137	CbGpPWpGaD
Pimozide—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000107	0.00137	CbGpPWpGaD
Pimozide—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000106	0.00136	CbGpPWpGaD
Pimozide—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000105	0.00135	CbGpPWpGaD
Pimozide—OPRM1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000103	0.00133	CbGpPWpGaD
Pimozide—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000103	0.00132	CbGpPWpGaD
Pimozide—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000102	0.00131	CbGpPWpGaD
Pimozide—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000101	0.0013	CbGpPWpGaD
Pimozide—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000101	0.0013	CbGpPWpGaD
Pimozide—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.0001	0.00129	CbGpPWpGaD
Pimozide—OPRM1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.0001	0.00129	CbGpPWpGaD
Pimozide—HTR6—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.0001	0.00129	CbGpPWpGaD
Pimozide—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	9.99e-05	0.00128	CbGpPWpGaD
Pimozide—DRD3—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	9.94e-05	0.00128	CbGpPWpGaD
Pimozide—DRD3—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	9.94e-05	0.00128	CbGpPWpGaD
Pimozide—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	9.94e-05	0.00128	CbGpPWpGaD
Pimozide—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	9.83e-05	0.00126	CbGpPWpGaD
Pimozide—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	9.81e-05	0.00126	CbGpPWpGaD
Pimozide—HRH1—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	9.66e-05	0.00124	CbGpPWpGaD
Pimozide—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	9.65e-05	0.00124	CbGpPWpGaD
Pimozide—OPRM1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	9.35e-05	0.0012	CbGpPWpGaD
Pimozide—DRD3—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	9.26e-05	0.00119	CbGpPWpGaD
Pimozide—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	9.16e-05	0.00117	CbGpPWpGaD
Pimozide—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	9.14e-05	0.00117	CbGpPWpGaD
Pimozide—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	8.99e-05	0.00115	CbGpPWpGaD
Pimozide—HTR1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	8.93e-05	0.00114	CbGpPWpGaD
Pimozide—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	8.67e-05	0.00111	CbGpPWpGaD
Pimozide—HTR1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	8.66e-05	0.00111	CbGpPWpGaD
Pimozide—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	8.64e-05	0.00111	CbGpPWpGaD
Pimozide—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	8.6e-05	0.0011	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—HDC—Gilles de la Tourette syndrome	8.53e-05	0.00109	CbGpPWpGaD
Pimozide—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	8.52e-05	0.00109	CbGpPWpGaD
Pimozide—CALM3—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	8.48e-05	0.00109	CbGpPWpGaD
Pimozide—CALM1—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	8.2e-05	0.00105	CbGpPWpGaD
Pimozide—CALM2—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	8.2e-05	0.00105	CbGpPWpGaD
Pimozide—HTR1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	8.07e-05	0.00104	CbGpPWpGaD
Pimozide—DRD2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	7.84e-05	0.00101	CbGpPWpGaD
Pimozide—OPRK1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	7.75e-05	0.000994	CbGpPWpGaD
Pimozide—HTR2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	7.71e-05	0.000989	CbGpPWpGaD
Pimozide—HRH1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	7.69e-05	0.000987	CbGpPWpGaD
Pimozide—HTR6—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	7.64e-05	0.00098	CbGpPWpGaD
Pimozide—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	7.61e-05	0.000976	CbGpPWpGaD
Pimozide—DRD2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	7.61e-05	0.000976	CbGpPWpGaD
Pimozide—CHRM2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	7.57e-05	0.000971	CbGpPWpGaD
Pimozide—HTR2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	7.49e-05	0.00096	CbGpPWpGaD
Pimozide—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	7.47e-05	0.000958	CbGpPWpGaD
Pimozide—HRH1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	7.47e-05	0.000958	CbGpPWpGaD
Pimozide—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	7.42e-05	0.000952	CbGpPWpGaD
Pimozide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	7.35e-05	0.000943	CbGpPWpGaD
Pimozide—CHRM2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	7.35e-05	0.000943	CbGpPWpGaD
Pimozide—HTR2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	6.97e-05	0.000895	CbGpPWpGaD
Pimozide—HRH1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	6.96e-05	0.000893	CbGpPWpGaD
Pimozide—OPRK1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.91e-05	0.000887	CbGpPWpGaD
Pimozide—CHRM2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	6.85e-05	0.000878	CbGpPWpGaD
Pimozide—HTR6—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.81e-05	0.000874	CbGpPWpGaD
Pimozide—OPRK1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6.71e-05	0.000861	CbGpPWpGaD
Pimozide—HTR6—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6.62e-05	0.000849	CbGpPWpGaD
Pimozide—OPRM1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	6.55e-05	0.00084	CbGpPWpGaD
Pimozide—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	6.52e-05	0.000836	CbGpPWpGaD
Pimozide—DRD3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	6.49e-05	0.000832	CbGpPWpGaD
Pimozide—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	6.4e-05	0.000821	CbGpPWpGaD
Pimozide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	6.3e-05	0.000808	CbGpPWpGaD
Pimozide—OPRK1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	6.28e-05	0.000805	CbGpPWpGaD
Pimozide—OPRK1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	6.25e-05	0.000802	CbGpPWpGaD
Pimozide—HTR6—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	6.19e-05	0.000794	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—HDC—Gilles de la Tourette syndrome	6.18e-05	0.000792	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—HDC—Gilles de la Tourette syndrome	6.16e-05	0.000791	CbGpPWpGaD
Pimozide—HTR6—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	6.16e-05	0.000791	CbGpPWpGaD
Pimozide—CALM3—Metabolism—HDC—Gilles de la Tourette syndrome	6.14e-05	0.000787	CbGpPWpGaD
Pimozide—OPRK1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	6.1e-05	0.000782	CbGpPWpGaD
Pimozide—HTR6—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	6.01e-05	0.000771	CbGpPWpGaD
Pimozide—CALM2—Metabolism—HDC—Gilles de la Tourette syndrome	5.94e-05	0.000762	CbGpPWpGaD
Pimozide—CALM1—Metabolism—HDC—Gilles de la Tourette syndrome	5.94e-05	0.000762	CbGpPWpGaD
Pimozide—OPRM1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.84e-05	0.00075	CbGpPWpGaD
Pimozide—OPRK1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	5.68e-05	0.000728	CbGpPWpGaD
Pimozide—OPRM1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.67e-05	0.000728	CbGpPWpGaD
Pimozide—HTR1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.65e-05	0.000725	CbGpPWpGaD
Pimozide—DRD3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.62e-05	0.000721	CbGpPWpGaD
Pimozide—HTR6—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	5.6e-05	0.000718	CbGpPWpGaD
Pimozide—OPRM1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	5.31e-05	0.000681	CbGpPWpGaD
Pimozide—OPRM1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	5.28e-05	0.000678	CbGpPWpGaD
Pimozide—DRD3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	5.23e-05	0.000671	CbGpPWpGaD
Pimozide—OPRM1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.15e-05	0.000661	CbGpPWpGaD
Pimozide—DRD3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.1e-05	0.000655	CbGpPWpGaD
Pimozide—HTR1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.04e-05	0.000647	CbGpPWpGaD
Pimozide—DRD2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.96e-05	0.000637	CbGpPWpGaD
Pimozide—HTR1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.9e-05	0.000628	CbGpPWpGaD
Pimozide—HRH1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.87e-05	0.000625	CbGpPWpGaD
Pimozide—OPRM1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.8e-05	0.000616	CbGpPWpGaD
Pimozide—CHRM2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.8e-05	0.000615	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—HDC—Gilles de la Tourette syndrome	4.77e-05	0.000611	CbGpPWpGaD
Pimozide—DRD3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.75e-05	0.00061	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—HDC—Gilles de la Tourette syndrome	4.65e-05	0.000597	CbGpPWpGaD
Pimozide—HTR1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.58e-05	0.000588	CbGpPWpGaD
Pimozide—HTR1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.56e-05	0.000585	CbGpPWpGaD
Pimozide—HTR1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.45e-05	0.00057	CbGpPWpGaD
Pimozide—DRD2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.43e-05	0.000568	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	4.38e-05	0.000562	CbGpPWpGaD
Pimozide—OPRK1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.38e-05	0.000562	CbGpPWpGaD
Pimozide—HTR2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.36e-05	0.000559	CbGpPWpGaD
Pimozide—HRH1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.35e-05	0.000558	CbGpPWpGaD
Pimozide—HTR6—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.32e-05	0.000554	CbGpPWpGaD
Pimozide—DRD2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.3e-05	0.000552	CbGpPWpGaD
Pimozide—CHRM2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.28e-05	0.000549	CbGpPWpGaD
Pimozide—HTR2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.23e-05	0.000543	CbGpPWpGaD
Pimozide—HRH1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.22e-05	0.000541	CbGpPWpGaD
Pimozide—CHRM2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.15e-05	0.000533	CbGpPWpGaD
Pimozide—HTR1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.14e-05	0.000531	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.02e-05	0.000516	CbGpPWpGaD
Pimozide—OPRK1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.98e-05	0.00051	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.96e-05	0.000508	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.95e-05	0.000507	CbGpPWpGaD
Pimozide—HTR2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.94e-05	0.000506	CbGpPWpGaD
Pimozide—HRH1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.93e-05	0.000504	CbGpPWpGaD
Pimozide—HTR6—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.92e-05	0.000503	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.9e-05	0.000501	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.89e-05	0.000498	CbGpPWpGaD
Pimozide—CHRM2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.87e-05	0.000496	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.84e-05	0.000493	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.83e-05	0.000492	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.77e-05	0.000484	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—HDC—Gilles de la Tourette syndrome	3.71e-05	0.000476	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.71e-05	0.000476	CbGpPWpGaD
Pimozide—OPRM1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.7e-05	0.000475	CbGpPWpGaD
Pimozide—DRD3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.67e-05	0.00047	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.66e-05	0.000469	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.6e-05	0.000462	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.58e-05	0.000459	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.57e-05	0.000458	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.55e-05	0.000455	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.51e-05	0.000451	CbGpPWpGaD
Pimozide—ABCB1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	3.46e-05	0.000443	CbGpPWpGaD
Pimozide—OPRM1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.36e-05	0.000431	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.35e-05	0.00043	CbGpPWpGaD
Pimozide—DRD3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.33e-05	0.000427	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.31e-05	0.000424	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.28e-05	0.000421	CbGpPWpGaD
Pimozide—HTR1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.19e-05	0.00041	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.19e-05	0.000409	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.18e-05	0.000408	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.18e-05	0.000408	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.13e-05	0.000402	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.08e-05	0.000396	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.08e-05	0.000396	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.04e-05	0.00039	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.01e-05	0.000387	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.97e-05	0.000381	CbGpPWpGaD
Pimozide—HTR1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.9e-05	0.000372	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.87e-05	0.000369	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.87e-05	0.000369	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	2.87e-05	0.000368	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.83e-05	0.000364	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.81e-05	0.00036	CbGpPWpGaD
Pimozide—DRD2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.81e-05	0.00036	CbGpPWpGaD
Pimozide—HRH1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.75e-05	0.000353	CbGpPWpGaD
Pimozide—CHRM2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.71e-05	0.000348	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.71e-05	0.000347	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.63e-05	0.000337	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.55e-05	0.000327	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.5e-05	0.000321	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.46e-05	0.000316	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.45e-05	0.000314	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.38e-05	0.000305	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.35e-05	0.000301	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.34e-05	0.0003	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.33e-05	0.000299	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.32e-05	0.000297	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.31e-05	0.000296	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.3e-05	0.000294	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.27e-05	0.000291	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.26e-05	0.00029	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.23e-05	0.000286	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.11e-05	0.000271	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.11e-05	0.000271	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.08e-05	0.000267	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.08e-05	0.000266	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.01e-05	0.000258	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.01e-05	0.000258	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.99e-05	0.000255	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.97e-05	0.000252	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.94e-05	0.000249	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.88e-05	0.000242	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.88e-05	0.000241	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.88e-05	0.000241	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.82e-05	0.000234	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.82e-05	0.000234	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.75e-05	0.000225	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.71e-05	0.00022	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.7e-05	0.000218	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.7e-05	0.000218	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.5e-05	0.000193	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.48e-05	0.00019	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.45e-05	0.000186	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.23e-05	0.000158	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.19e-05	0.000153	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.19e-05	0.000153	CbGpPWpGaD
